Published in Biostatistics on March 08, 2010
Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology (2006) 1.93
Clinical trials and statistical verdicts: probable grounds for appeal. Ann Intern Med (1983) 1.19
Identification of pharmacogenetic markers in smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet (2008) 1.12
A Bayesian determination of threshold for identifying differentially expressed genes in microarray experiments. Stat Med (2006) 0.97
Synchronization of breast cancer cell proliferation in vivo by combined hormonal and polyamine manipulation. Cancer Res (1992) 0.91
Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc Natl Acad Sci U S A (2009) 5.36
Measuring agreement in medical informatics reliability studies. J Biomed Inform (2002) 5.00
Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. N Engl J Med (2012) 3.15
Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care Res (Hoboken) (2010) 2.94
Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Ann Intern Med (2010) 2.94
Multiple imputation for model checking: completed-data plots with missing and latent data. Biometrics (2005) 2.44
Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum (2009) 2.07
An index of local sensitivity to nonignorable drop-out in longitudinal modelling. Stat Med (2005) 2.00
Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol (2002) 1.93
Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med (2002) 1.89
Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. J Clin Oncol (2002) 1.68
A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leuk Lymphoma (2006) 1.67
Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma. Cancer Biol Ther (2008) 1.58
Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Ann Intern Med (2006) 1.57
A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring. Biometrics (2006) 1.50
A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clin Cancer Res (2007) 1.47
Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. J Clin Oncol (2002) 1.44
Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther (2010) 1.40
Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. Cancer Biol Ther (2009) 1.40
Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiol Biomarkers Prev (2012) 1.34
Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers. Clin Cancer Res (2008) 1.32
Modeling heaping in self-reported cigarette counts. Stat Med (2008) 1.29
Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology (2010) 1.17
A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Mol Ther (2010) 1.15
A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials. Clin Trials (2012) 1.10
Design and analysis of controlled trials in naturally clustered environments: implications for medical informatics. J Am Med Inform Assoc (2002) 1.07
A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma. Am J Respir Crit Care Med (2011) 1.07
Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Res Treat (2010) 1.07
Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study. Stat Med (2007) 1.02
Nonignorable censoring in randomized clinical trials. Clin Trials (2005) 0.99
Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Stat Med (2010) 0.99
Comparison between the analgesic efficacy of transversus abdominis plane (TAP) block and placebo in open retropubic radical prostatectomy: a prospective, randomized, double-blinded study. J Clin Anesth (2013) 0.99
A placebo-controlled trial of modafinil for nicotine dependence. Drug Alcohol Depend (2008) 0.98
Missing data in model-based pharmacometric applications: points to consider. J Clin Pharmacol (2010) 0.96
(31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan. NMR Biomed (2012) 0.95
Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice. BMC Cancer (2011) 0.94
Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin. NMR Biomed (2014) 0.94
Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients. Oncoimmunology (2013) 0.91
Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2011) 0.90
DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma. Clin Cancer Res (2005) 0.90
Sensitivity analysis of causal inference in a clinical trial subject to crossover. Clin Trials (2004) 0.89
A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumption. Nicotine Tob Res (2009) 0.88
Nonparametric prediction of event times in randomized clinical trials. Clin Trials (2004) 0.87
Occult breast tumor reservoir: biological properties and clinical significance. Horm Cancer (2013) 0.87
Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma. Ann Surg Oncol (2004) 0.85
Prediction of individual long-term outcomes in smoking cessation trials using frailty models. Biometrics (2011) 0.84
Incomplete data: what you don't know might hurt you. Cancer Epidemiol Biomarkers Prev (2011) 0.84
Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy. Cancer Epidemiol Biomarkers Prev (2012) 0.83
Impact of nonignorable coarsening on Bayesian inference. Biostatistics (2007) 0.83
The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. Ann Surg (2015) 0.83
MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib. AJR Am J Roentgenol (2013) 0.82
Weibull prediction of event times in clinical trials. Pharm Stat (2008) 0.81
Predicting event times in clinical trials when treatment arm is masked. J Biopharm Stat (2006) 0.81
Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer. Cancer Chemother Pharmacol (2013) 0.80
Effects of menopausal hormonal therapy on occult breast tumors. J Steroid Biochem Mol Biol (2013) 0.79
Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan. NMR Biomed (2015) 0.79
Statistical analysis of daily smoking status in smoking cessation clinical trials. Addiction (2011) 0.79
Assessing the fit of parametric cure models. Biostatistics (2012) 0.79
Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. Ann Am Thorac Soc (2013) 0.79
Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer. Ann Surg Oncol (2005) 0.78
Predicting event times in clinical trials when randomization is masked and blocked. Clin Trials (2007) 0.77
Prediction of event times in the REMATCH Trial. Clin Trials (2013) 0.77
Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial. Stat Med (2012) 0.75
A pattern-mixture model for the analysis of censored quality-of-life data. Stat Med (2006) 0.75
Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? BJU Int (2008) 0.75